AT

Aaron Tabor

Chief Science Officer

Axolotl Biologix

Therapeutic Areas

Axolotl Biologix Pipeline

DrugIndicationPhase
Axolotl Graft Portfolio Clinical ValidationWound Healing / Tissue RepairPost-Market Study